ARYx Therapeutics, Inc.
ARYX
$0.00
$0.000.00%
OTC PK
| 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | 09/30/2009 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.95M | 1.40M | 6.30M | 7.76M | 14.19M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 578.00K | 633.00K | 822.00K | 895.00K | 764.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 150.00K | 150.00K | 150.00K | 150.00K | 150.00K |
| Total Current Assets | 3.68M | 2.19M | 7.27M | 8.81M | 15.10M |
|
|
|||||
| Total Current Assets | 3.68M | 2.19M | 7.27M | 8.81M | 15.10M |
| Net Property, Plant & Equipment | 1.58M | 1.78M | 2.01M | 2.26M | 2.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 712.00K | 1.06M | 1.30M | 1.34M | 1.72M |
| Total Assets | 5.97M | 5.02M | 10.58M | 12.41M | 19.29M |
|
|
|||||
| Total Accounts Payable | 233.00K | 443.00K | 197.00K | 685.00K | 1.10M |
| Total Accrued Expenses | 731.00K | 2.37M | 2.95M | 2.81M | 2.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.83M | 3.34M | 4.10M | 4.85M | 6.79M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 333.00K | -- |
| Total Other Current Liabilities | -- | -- | -- | 333.00K | -- |
| Total Current Liabilities | 7.79M | 6.15M | 7.25M | 8.68M | 9.95M |
|
|
|||||
| Total Current Liabilities | 7.79M | 6.15M | 7.25M | 8.68M | 9.95M |
| Long-Term Debt | 4.75M | 3.56M | 4.44M | 5.28M | 6.37M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.17M | 1.23M | 1.30M | 1.36M | 1.15M |
| Total Liabilities | 13.71M | 10.95M | 12.98M | 15.32M | 17.47M |
|
|
|||||
| Common Stock & APIC | 191.92M | 191.20M | 191.10M | 184.19M | 183.14M |
| Retained Earnings | -199.65M | -197.14M | -193.50M | -187.11M | -181.32M |
| Treasury Stock & Other | -- | -- | -- | -- | 2.00K |
| Total Common Equity | -7.74M | -5.93M | -2.40M | -2.92M | 1.82M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.74M | -5.93M | -2.40M | -2.92M | 1.82M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.74M | -5.93M | -2.40M | -2.92M | 1.82M |
|
|
|||||